No antipsychotic currently on the market is reliably associated with weight loss. Most cause some degree of weight gain, and a few are essentially weight-neutral, meaning they cause little to no change in body weight compared to placebo. If you’ve gained weight on your current medication, the practical question becomes which alternatives carry the least metabolic burden and what strategies can help reverse the weight you’ve already put on.
Why Most Antipsychotics Cause Weight Gain
Antipsychotics work by blocking certain receptors in the brain, and some of those same receptors play a role in appetite, metabolism, and how your body handles insulin. The medications that cause the most weight gain tend to block histamine receptors (which regulate hunger signals), serotonin receptors (which influence satiety and insulin function), and a type of receptor in the nervous system involved in glucose regulation. The more of these receptors a drug blocks, the greater its potential to increase appetite and shift your metabolism toward fat storage.
This is why weight gain varies so dramatically between medications. In a large network analysis published in The Lancet Psychiatry comparing 18 antipsychotics, average weight gain ranged from virtually nothing with some older drugs to about 3 kg (roughly 6.5 pounds) with clozapine. The drugs with the worst metabolic profiles, olanzapine and clozapine, hit nearly all of the receptors linked to weight regulation. The ones with the lightest metabolic footprint tend to be more selective in which receptors they target.
The Most Weight-Neutral Options
Five antipsychotics consistently show the most favorable metabolic profiles: aripiprazole, brexpiprazole, cariprazine, lurasidone, and ziprasidone. These medications still carry some risk of modest weight change, but across large studies, they produce significantly less weight gain than drugs like olanzapine or clozapine.
Aripiprazole is the most widely studied of the group. It works differently from most antipsychotics because it’s a partial agonist, meaning it partially activates certain receptors rather than fully blocking them. While it’s often described as weight-neutral, the picture is more nuanced. Higher doses are linked to greater weight gain early in treatment, but that relationship reverses after about five months. Over a full year, each 5 mg increase in dose was associated with a 30% higher chance of gaining 7% or more of body weight. So even with a “weight-neutral” drug, dose matters.
Haloperidol, an older first-generation antipsychotic, also showed minimal weight impact in the Lancet Psychiatry analysis, with an average change of negative 0.23 kg compared to placebo. However, older antipsychotics come with their own set of side effects, particularly movement-related problems, which is why they’re not always a preferred alternative.
Molindone: A Historical Outlier
One antipsychotic that has been linked to weight loss in some patients is molindone, an older medication. According to its FDA-approved labeling, both weight gain and weight loss have been observed, generally moving patients toward a more normal weight rather than causing excessive gain. Molindone is no longer widely available or commonly prescribed, but it remains a notable exception in the literature for its unusual weight profile.
What Happens When You Switch Medications
If you’ve gained weight on a medication like olanzapine or clozapine, switching to a lighter-profile drug can reverse some of that gain. A systematic review and meta-analysis looking at the reversibility of antipsychotic weight gain found that simply discontinuing a weight-promoting antipsychotic led to an average loss of about 1.6 kg. But the most effective switch was to a partial agonist like aripiprazole, which produced an average loss of 3.19 kg (about 7 pounds).
That loss is meaningful but modest. It won’t fully reverse significant weight gain on its own, and switching medications always involves a trade-off: the new drug needs to control your psychiatric symptoms just as well. Reducing the dose of your current antipsychotic without switching showed almost no weight benefit, with an average loss of less than half a kilogram that wasn’t statistically significant.
Add-On Medications That Promote Weight Loss
When switching antipsychotics isn’t possible or doesn’t produce enough weight loss, several add-on medications have solid evidence behind them.
Metformin
Metformin, a medication originally developed for type 2 diabetes, is the most widely studied add-on for antipsychotic-related weight gain. Across pooled studies, it produces an average weight loss of about 3.3 kg (roughly 7 pounds) and reduces BMI by about 1.24 points. Interestingly, lower doses (1,000 mg per day or less) showed slightly more weight loss in the data than higher doses, though both were effective. Current guidelines typically recommend starting at 500 mg twice daily and increasing gradually up to 2,000 mg per day.
Topiramate
Topiramate, an anti-seizure medication, ranks as one of the most effective add-on treatments for antipsychotic weight gain. In a network meta-analysis comparing several adjunct medications, topiramate produced an average weight reduction of about 3.07 kg and the largest BMI reduction of any add-on studied, at 1.59 points. It ranked above metformin for both weight and BMI reduction. The most common side effect is tingling or numbness in the hands and feet, though adverse effects were generally mild to moderate across studies.
Semaglutide
The newest and most dramatic results come from semaglutide, a GLP-1 receptor agonist originally developed for diabetes and obesity. In a 36-week trial of people with schizophrenia taking clozapine (one of the most weight-promoting antipsychotics), weekly semaglutide reduced body weight by nearly 14% compared to a small gain with placebo. Two-thirds of participants on semaglutide lost more than 10% of their body weight. That level of weight loss is comparable to what semaglutide achieves in the general population and far exceeds the results seen with metformin or topiramate. Importantly, it did not worsen psychotic symptoms or interfere with clozapine levels in the blood.
Putting It All Together
The realistic range of options looks like this: if you’re on a high-risk antipsychotic and weight gain is a serious concern, switching to aripiprazole, brexpiprazole, cariprazine, lurasidone, or ziprasidone offers the best chance of stopping further gain and modestly reversing what’s already happened. If switching isn’t an option because your current medication is the only one that adequately controls your symptoms, adding metformin or topiramate can produce losses in the range of 3 kg. Semaglutide represents a substantially more powerful tool, though access and cost remain barriers for many people.
No antipsychotic will act as a weight-loss drug on its own. But understanding the metabolic differences between these medications gives you a more informed conversation to have about balancing psychiatric stability with physical health.